17 April, 2018

The FDA is holding a meeting to consider approving Cannabidiol - a cannabinoid prepared from the Cannabis sativa L. plant - for a set of severe childhood seizure disorders.


No comments:

Post a Comment

I will publish your valuable comment after reviewing it. Thanks for your patience!